HuGE Literature Finder
Records
1
-
30
| Randomized phase II trial of FOLFIRI-panitumumab compared with FOLFIRI alone in patients with RAS wild-type circulating tumor DNA metastatic colorectal cancer beyond progression to first-line FOLFOX-panitumumab: the BEYOND study (GEMCAD 17-01). Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2022 Jun . Aparicio Jorge, Virgili Manrique Anna C, Capdevila Jaume, Muñoz Boza Félix, Galván Patricia, Richart Paula, Oliveres Helena, Páez David, Hernando Jorge, Serrano Sara, Vera Ruth, Hernandez-Yagüe Xavier, Gallego Rafael Álvarez, Riesco-Martinez M Carmen, García de Albeniz Xavier, Maurel Jo |
| Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studies. European journal of cancer (Oxford, England : 1990) 2022 May 170 64-72. Rossini Daniele, Germani Marco M, Lonardi Sara, Pietrantonio Filippo, Dell'Aquila Emanuela, Borelli Beatrice, Allegrini Giacomo, Maddalena Giulia, Randon Giovanni, Marmorino Federica, Zaniboni Alberto, Buonadonna Angela, Boccaccino Alessandra, Conca Veronica, Antoniotti Carlotta, Passardi Alessandro, Masi Gianluca, Cremolini Chia |
| Genetic characteristics and response to systemic therapies of acral lentiginous melanoma at a tertiary care center-a retrospective review. Journal of the National Medical Association 2021 Sep . Jamerson Taylor, Rebecca Vito W, Aguh Cryst |
| Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial. JAMA oncology 2021 Aug . Martinelli Erika, Martini Giulia, Famiglietti Vincenzo, Troiani Teresa, Napolitano Stefania, Pietrantonio Filippo, Ciardiello Davide, Terminiello Marinella, Borrelli Carola, Vitiello Pietro Paolo, De Braud Filippo, Morano Federica, Avallone Antonio, Normanno Nicola, Nappi Anna, Maiello Evaristo, Latiano Tiziana, Falcone Alfredo, Cremolini Chiara, Rossini Daniele, Santabarbara Giuseppe, Pinto Carmine, Santini Daniele, Cardone Claudia, Zanaletti Nicoletta, Di Liello Alessandra, Renato Daniela, Esposito Lucia, Marrone Francesca, Ciardiello Fortuna |
| Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/NRAS/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients. Journal of clinical laboratory analysis 2021 Aug e23818. Xu Xiaojing, Huang Fei, Cao Minlu, Chen Xinning, Wang Hao, Jiang Huiqin, Yu Yiyi, Shen Minna, Yang Yihui, Wang Beili, Liu Tianshu, Guo W |
| Phase II Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Metastatic Colorectal Cancer. Clinical colorectal cancer 2021 Jul . Alshammari Kanan, Aung Kyaw L, Zhang Tong, Razak Albiruni R A, Serra Stefano, Stockley Tracy, Wang Lisa, Nguyen Jessica, Spreafico Anna, Hansen Aaron R, Zwir Dave, Siu Lillian L, Bedard Philippe |
| Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute Study. Cancers 2021 Jun 13 (13): . Liszkay Gabriella, Mátrai Zoltán, Czirbesz Kata, Jani Nóra, Bencze Eszter, Kenessey Istv |
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
| Incidence of Intracranial Melanoma Progression in the Setting of Positive Extracranial Response to Targeted Therapy and Immunotherapy: An Indication for More Frequent Screening in This Population? Cureus 2021 Mar 13 (3): e13648. Gattozzi Domenico A, Rosso Casey, Schatmeyer Bryan A, Kabangu Jean-Luc K, Doolittle Gary C, Wang Fen, Stepp Timot |
| Prevalence of colorectal cancer biomarkers and their impact on clinical outcomes in Riyadh, Saudi Arabia. PloS one 2021 16 (5): e0249590. Alharbi Amjad, Bin Dokhi Haifa, Almuhaini Ghadir, Alomran Futoon, Masuadi Emad, Alomran No |
| MAP2K1 Mutations in Advanced Colorectal Cancer Predict Poor Response to Anti-EGFR Therapy and to Vertical Targeting of MAPK Pathway. Clinical colorectal cancer 2020 Dec . Chuang Jeremy, Wang Chongkai, Guo Yuming, Valenzuela Valerie, Wu Jun, Fakih Marw |
| Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA. EBioMedicine 2020 Nov 62 103103. Dietz Steffen, Christopoulos Petros, Yuan Zhao, Angeles Arlou Kristina, Gu Lisa, Volckmar Anna-Lena, Ogrodnik Simon J, Janke Florian, Fratte Chiara Dalle, Zemojtel Tomasz, Schneider Marc A, Kazdal Daniel, Endris Volker, Meister Michael, Muley Thomas, Cecchin Erika, Reck Martin, Schlesner Matthias, Thomas Michael, Stenzinger Albrecht, Sültmann Holg |
| ctDNA in neuroendocrine carcinoma of gastroenteropancreatic origin or of unknown primary: the CIRCAN-NEC pilot study. Neuroendocrinology 2020 Oct . Gerard Laura, Garcia Jessica, Gauthier Arnaud, Lopez Jonathan, Durand Alice, Hervieu Valérie, Lemelin Annie, Chardon Laurence, Landel Verena, Gibert Benjamin, Lombard-Bohas Catherine, Payen Lea, Walter Thom |
| Dynamic analysis of circulating tumor DNA to predict prognosis and monitor therapeutic response in metastatic relapsed cervical cancer. International journal of cancer 2020 Oct . Tian Xiaoyuan, Ge Dongcen, Zhang Feng, Zhang Bocheng, Bai Wanting, Xu Xiaoying, Li Zongjuan, Cao Ying, Li Peiying, Zou Kun, Zou Liju |
| Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial. British journal of cancer 2020 Feb . Aparicio Thomas, Bennouna Jaafar, Le Malicot Karine, Boige Valérie, Taieb Julien, Bouché Olivier, Phelip Jean-Marc, François Eric, Borel Christian, Faroux Roger, Dahan Laetitia, Bachet Jean-Baptiste, Egreteau Joelle, Kaminsky Marie-Christine, Gornet Jean-Marc, Cojocarasu Oana, Gasmi Mohamed, Guerin-Meyer Véronique, Lepage Côme, Ghiringhelli François, |
| Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population. Disease markers 2020 2020 8459303. El Otmani Ihsane, El Agy Fatima, El Baradai Sanae, Bouguenouch Laila, Lahmidani Nada, El Abkari Mohammed, Benajah Dafr Allah, Toughrai Imane, El Bouhaddouti Hicham, Mouaqit Ouadii, Ibn Majdoub Hassani Karim, Mazaz Khalid, Benjelloun El Bachir, Ousadden Abdelmalek, El Rhazi Karima, Bouhafa Touria, Benbrahim Zineb, Ouldim Karim, Ibrahimi Sidi Adil, Ait Taleb Khalid, Chbani Lai |
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
| TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical genitourinary cancer 2019 Nov . Chapman Lynne, Ledet Elisa M, Barata Pedro C, Cotogno Patrick, Manogue Charlotte, Moses Marcus, Christensen Bryce R, Steinwald Peter, Ranasinghe Lahiru, Layton Jodi L, Lewis Brian E, Sartor Oliv |
| Circulating tumor cell free DNA from plasma and urine in the clinical management of colorectal cancer. Cancer biomarkers : section A of Disease markers 2019 Oct . Yu Haiying, Han Lan, Yuan Jia, Sun Yiny |
| Plasma next generation sequencing and droplet digital PCR-based detection of epidermal growth factor receptor (EGFR) mutations in patients with advanced lung cancer treated with subsequent-line osimertinib. Thoracic cancer 2019 Aug . Ding Pei N, Becker Therese, Bray Victoria, Chua Wei, Ma Yafeng, Xu Bo, Lynch David, de Souza Paul, Roberts Ta |
| BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases. The British journal of surgery 2019 Jun . Bachet J-B, Moreno-Lopez N, Vigano L, Marchese U, Gelli M, Raoux L, Truant S, Laurent C, Herrero A, Le Roy B, Deguelte Lardiere S, Passot G, Hautefeuille V, De La Fouchardiere C, Artru P, Ameto T, Mabrut J Y, Schwarz L, Rousseau B, Lepère C, Coriat R, Brouquet A, Sa Cunha A, Benoist |
| BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis. Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2019 May 1093526619847859. Ozer Erdener, Sevinc Akin, Ince Dilek, Yuzuguldu Resmiye, Olgun N |
| Phase II study of high-sensitivity genotyping of KRAS, NRAS, BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial. Annals of oncology : official journal of the European Society for Medical Oncology 2019 Mar . Santos C, Azuara D, Viéitez J M, Páez D, Falcó E, Élez E, López-López C, Valladares M, Robles-Díaz L, García-Alfonso P, Bugés C, Durán G, Salud A, Navarro V, Capellá G, Salazar R, Aranda |
| TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma. Endocrine 2018 Jun . Penna Gustavo C, Pestana Ana, Cameselle José Manuel, Momesso Denise, de Andrade Fernanda Accioly, Vidal Ana Paula Aguiar, Araujo Junior Mario Lucio, Melo Miguel, Fernandes Priscila Valverde, Corbo Rossana, Vaisman Mario, Sobrinho-Simões Manuel, Soares Paula, Vaisman Fernan |
| The genetic landscape of ganglioglioma. Acta neuropathologica communications 2018 Jun 6 (1): 47. Pekmezci Melike, Villanueva-Meyer Javier E, Goode Benjamin, Van Ziffle Jessica, Onodera Courtney, Grenert James P, Bastian Boris C, Chamyan Gabriel, Maher Ossama M, Khatib Ziad, Kleinschmidt-DeMasters Bette K, Samuel David, Mueller Sabine, Banerjee Anuradha, Clarke Jennifer L, Cooney Tabitha, Torkildson Joseph, Gupta Nalin, Theodosopoulos Philip, Chang Edward F, Berger Mitchel, Bollen Andrew W, Perry Arie, Tihan Tarik, Solomon David |
| Frequency of MAP2K1, TP53, and U2AF1 Mutations in BRAF-mutated Langerhans Cell Histiocytosis: Further Characterizing the Genomic Landscape of LCH. The American journal of surgical pathology 2018 Apr . McGinnis Lisa M, Nybakken Grant, Ma Lisa, Arber Daniel |
| Detection of EGFR, KRAS and BRAF mutations in metastatic cells from cerebrospinal fluid. Clinical chemistry and laboratory medicine 2018 04 56 (5): 748-753. Frankel Diane, Nanni-Metellus Isabelle, Robaglia-Schlupp Andrée, Tomasini Pascale, Guinde Julien, Barlesi Fabrice, Astoul Philippe, Ouafik L'Houcine, Amatore Florent, Secq Véronique, Kaspi Elise, Roll Patri |
| Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer. Clinical colorectal cancer 2018 09 17 (3): 206-214. Kim Tae Won, Elme Anneli, Park Joon Oh, Udrea Anghel Adrian, Kim Sun Young, Ahn Joong Bae, Valencia Ricardo Villalobos, Krishnan Srinivasan, Manojlovic Nebojsa, Guan Xuesong, Lofton-Day Catherine, Jung A Scott, Vrdoljak Edua |
| Integrating TYMS, KRAS and BRAF testing in patients with metastatic colorectal cancer. World journal of gastroenterology 2017 Aug 23 (32): 5913-5924. Ntavatzikos Anastasios, Spathis Aris, Patapis Paul, Machairas Nikolaos, Peros George, Konstantoudakis Stefanos, Leventakou Danai, Panayiotides Ioannis G, Karakitsos Petros, Koumarianou An |
| Telomere shortening in non-tumorous and tumor mucosa is independently related to colorectal carcinogenesis in precancerous lesions. International journal of molecular epidemiology and genetics 2017 8 (5): 53-58. Park Won-Jin, Bae Sung Uk, Heo Yu-Ran, Jung Soo-Jung, Lee Jae- |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: